This is not a modular budget.......it is a detailed multiproject  U54
center grant.

Robert Gregory Miller
Charles R. Drew University of Medicine and Science
Div. of Endocrinology, Metabolism and Molecular Science
Administrative Director/Research Administrator
xxxxxx@cdrewu.edu
Office: 323.563.5961
Fax: 323.563.5966

Notice of Confidentiality

This message contains information that may be confidential or
privileged.

It is intended for the exclusive use of the addressee or any person
entitled to receive it.  If you received this message in error,
please inform the author as soon as possible, do not disclose its
contents and delete it from your system

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On
Behalf Of Manuela Dokie
Sent: Thursday, August 18, 2005 11:42 AM
To: xxxxxx@HRINET.ORG
Subject: Re: [RESADM-L] Checklist / F&A costs

Hi:
If this is NIH format, the separated F&A is not detailed on the
checklist because on the checklist the consortium/contractual F&A
costs become part of the requester's direct costs.  However, the
budget forms (Form Pages 4 and , and the Modular Format) require you
list the Consortium/Contractual F&A as a separate line item.  If the
consortium partner's F&A is not part of the requester's MTDC on the
check list, but is listed separately, the requester could not
accurately calculate their own F&A.
Regards,
Manuela

Manuela Dokie
Senior Research Administrator
Office of Sponsored Programs
University of Nevada Las Vegas
Phone:  (702) 895-1357
Fax:  (702) 895-0986

 Robert Miller <xxxxxx@CDREWU.EDU>
Sent by: Research Administration List <xxxxxx@HRINET.ORG>

08/18/2005 10:39 AM
Please respond to Research Administration Discussion List

 To:        xxxxxx@HRINET.ORG
 cc:
 Subject:        [RESADM-L] Checklist / F&A costs

Master-budgeteers...

One of my PI's seems to think that when completing the checklist (non
competing continuation) you must separately list the F&A of the
consortium contract (on the check list). I disagree, the instructions
does not state so as the direct costs of the primary encompasses the
F&A of the consortium contract.

Your input would help.

Thanks

Robert Gregory Miller
Charles R. Drew University of Medicine and Science
Div. of Endocrinology, Metabolism and Molecular Science
Administrative Director/Research Administrator
xxxxxx@cdrewu.edu
Office: 323.563.5961
Fax: 323.563.5966

Notice of Confidentiality

This message contains information that may be confidential or
privileged.

It is intended for the exclusive use of the addressee or any person
entitled to receive it.  If you received this message in error,
please inform the author as soon as possible, do not disclose its
contents and delete it from your system

======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================